Assessment of Cardiovascular Risk Factors Among Sudanese Patients with Type 2 Diabetes
Background: Individuals with type 2 diabetes who have optimum condition management are exposed to a significantly higher risk of developing cardiovascular disease (CVD) compared to those who do not have diabetes. People with diabetes are estimated to have a fourfold greater risk of developing CVD than people without diabetes. CVD risk factors other than diabetes include older age, obesity hypertension, dyslipidemia, smoking, and a family history of coronary or kidney diseases.
Objectives: The study aims to assess the cardiovascular risk factors among type2 diabetes at Ribat Hospital Diabetes Clinic, Sudan.
Methods: T2 DM patients were evaluated for the presence of CVD risk factors by using data collecting form to extract data verbally and from patients’ files.
Results: Out of 147 T2 DM files, 92 (61.7 %) were female, 57 (38.3 %) were male, and 58 (38.9 %) patients were ≥ 60 year old. Patients who had poor glycemic control were 112 (75.2 %) and those who met the glycemic target were only 37 (24.8 %). Older age (P = 0.01) and diabetes duration (P = 0.026) were associated with poor glycemic control. Prevalence of hypertension was 61 (40.9 %), dyslipidemia 31 (20.8 %), and physical inactivity 112 (75.2 %). All patients had at least one CVD risk factor and those having all three risk factors were 48 (32.2 %).
Conclusion: All T2 DM diabetic patients in RHDC had at least one CVD risk factor and almost a third of them had all three risk factors. Poor glycemic control, physical inactivity, hypertension, and age ≥ 60 had a higher prevalence of CVD risk factors.
 Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., Huikuri, H. V., Johansson, I., Jüni, P., Lettino, M., Marx, N., Mellbin, L. G., Östgren, C. J., Rocca, B., Roffi, M., . . . Wheeler, D. C., & the ESC Scientific Document Group. (2020). 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal, 41, 255–323.
 Wright, A. K., Suarez-Ortegon, M. F., Read, S. H., Kontopantelis, E., Buchan, I., Emsley, R., Sattar, N., Ashcroft, D. M., Wild, S. H., & Rutter, M. K. (2020). Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings. Circulation, 142, 1925–1936.
 Buyken, A. E., von Eckardstein, A., Schulte, H., Cullen, P., & Assmann, G. (2007). Type 2 diabetes mellitus and risk of coronary heart disease: Results of the 10-year follow-up of the PROCAM study. European Journal of Cardiovascular Prevention and Rehabilitation, 14, 230–236.
 Ohira, T., Shahar, E., Chambless, L. E., Rosamond, W. D., Mosley, T. H., Jr., & Folsom, A. R. (2006). Risk factors for ischemic stroke subtypes: The atherosclerosis risk in communities study. Stroke, 37, 2493–2498.
 Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018). Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovascular Diabetology, 17, 83.
 Group, U. P. D. S., & the UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837–853.
 Gaede, P., Vedel, P., Larsen, N., Jensen, G. V., Parving, H.-H., & Pedersen, O. (2003). Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England Journal of Medicine, 348, 383–393.
 Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C., & Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ (Clinical Research Ed.), 321, 405–412.
 Association, A. (2020). American diabetes association standards of medical care in diabetes-2020. Diabetes Care, 43, S14–S31.
 Alramadan, M. J., Magliano, D. J., Almigbal, T. H., Batais, M. A., Afroz, A., Alramadhan, H. J., Mahfoud, W. F., Alragas, A. M., & Billah, B. (2018). Glycaemic control for people with type 2 diabetes in Saudi Arabia - an urgent need for a review of management plan. BMC Endocrine Disorders, 18, 62.
 Cade, W. T. (2008). Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Physical Therapy, 88, 1322–1335.
 American Diabetes Association. (2019). 10. Cardiovascular disease and risk management: Standards of medical care in diabetes—2019. Diabetes Care, 42(Suppl 1), S103–S123.
 Collins, R., Armitage, J., Parish, S., Sleigh, P., Peto, R., & the Heart Protection Study Collaborative Group. (2003). MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet, 361, 2005–2016.
 Alzaheb, R. A., & Altemani, A. H. (2018). The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes, Metabolic Syndrome and Obesity, 11, 15–21.
 Khattab, M., Khader, Y. S., Al-Khawaldeh, A., & Ajlouni, K. (2010). Factors associated with poor glycemic control among patients with type 2 diabetes. Journal of Diabetes and Its Complications, 24, 84–89.
 Almetwazi, M., Alwhaibi, M., Balkhi, B., Almohaini, H., Alturki, H., Alhawassi, T., Ata, S., AlQahtani, N., Mahmoud, M., & Alshammari, T. (2019). Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia. Saudi Pharmaceutical Journal, 27, 384–388.
 Salman, R. A., & Al-Rubeaan, K. A. (2009). Incidence and risk factors of hypertension among Saudi type 2 diabetes adult patients: An 11-year prospective randomized study. Journal of Diabetes and Its Complications, 23, 95–101.
 Lastra, G., Syed, S., Kurukulasuriya, L. R., Manrique, C., & Sowers, J. R. (2014). Type 2 diabetes mellitus and hypertension: An update. Endocrinology and Metabolism Clinics, 43, 103–122.
 Gurudut, P., & Rajan, A. P. (2017). Immediate effect of passive static stretching versus resistance exercises on postprandial blood sugar levels in type 2 diabetes mellitus: A randomized clinical trial. Journal of Exercise Rehabilitation, 13, 581–587.
 Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., Braun, B., & the American College of Sports Medicine, & the American Diabetes Association. (2010). Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care, 33, e147–e167.
 Hayes, L. D., Grace, F. M., Sculthorpe, N., Herbert, P., Ratcliffe, J. W., Kilduff, L. P., & Baker, J. S. (2013). The effects of a formal exercise training programme on salivary hormone concentrations and body composition in previously sedentary aging men. SpringerPlus, 2, 18.
 Duclos, M., Oppert, J. -M., Verges, B., Coliche, V., Gautier, J. -F., Guezennec, Y., Reach, G., Strauch, G., & the SFD diabetes and physical activity working group. (2013). Physical activity and type 2 diabetes. Recommendations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group. Diabetes & Metabolism, 39, 205–216.
 Kamuhabwa, A. R., & Charles, E. (2014). Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. [PubMed.]. Drug, Healthcare and Patient Safety, 6, 155–165.
 Sibai, A. M., Costanian, C., Tohme, R., Assaad, S., & Hwalla, N. (2013). Physical activity in adults with and without diabetes: From the ‘high-risk’ approach to the ‘population-based’ approach of prevention. BMC Public Health, 13, 1002.
 Parajuli, J., Saleh, F., Thapa, N., & Ali, L. (2014). Factors associated with nonadherence to diet and physical activity among Nepalese type 2 diabetes patients: A cross sectional study. BMC Research Notes, 7, 758.
 Hirano, T. (2018). Pathophysiology of diabetic dyslipidemia. Journal of Atherosclerosis and Thrombosis, 25, 771–782.
 Haile, K., & Timerga, A. (2020). Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at Jimma University Medical Center, Jimma, Southwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity, 13, 4589–4597.
 Chamba, N. G., Shao, E. R., Sonda, T., & Lyaruu, I. A. (2017). Lipid profile of Type 2 diabetic patients at a tertiary hospital in Tanzania: Cross sectional study. Journal of Endocrinology and Diabetes, 4, 1–6.
 Hussein, A., Mahmoud, S. E. D., Awad, M. S., & Mahmoud, H. E. M. (2020). Assessment of cardiovascular risk factors in patients with type 2 diabetes in upper Egypt villages. Diabetes, Metabolic Syndrome and Obesity, 13, 4737–4746.
 Halter, J. B., Musi, N., McFarland Horne, F., Crandall, J. P., Goldberg, A., Harkless, L., Hazzard, W. R., Huang, E. S., Kirkman, M. S., Plutzky, J., Schmader, K. E., Zieman, S., & High, K. P. (2014). Diabetes and cardiovascular disease in older adults: Current status and future directions. Diabetes, 63, 2578–2589.
 Bello-Ovosi, B. O., Ovosi, J. O., Ogunsina, M. A., Asuke, S., & Ibrahim, M. S. (2019). Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria. The Pan African Medical Journal, 34, 123.
 Kalofoutis, C., Piperi, C., Kalofoutis, A., Harris, F., Phoenix, D., & Singh, J. (2007). Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches. Experimental and Clinical Cardiology, 12, 17–28.
 Al Slail, F. Y., Abid, O., Assiri, A. M., Memish, Z. A., & Ali, M. K. (2016).Cardiovascular risk profiles of adults with type-2 diabetes treated at urban hospitals in Riyadh, Saudi Arabia. Journal of Epidemiology and Global Health, 6(1): 29–36.